U.S. President Donald Trump’s tariff announcements and the countermeasures declared by trade partners dominated the week, hitting Wall Street stocks to mark historic declines. The S&P 500 index was ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

Donald Trump’s team gutted the Biden administration’s plan as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug coverage ...

The world is reacting to new, sweeping tariffs announced by President Donald Trump on Wednesday -- a date his administration ...

Journalist Chris Whipple’s upcoming book reveals what Donald Trump told Kamala Harris after she called him to official ...

President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...

The injectable drugs have exploded in popularity due to the potentially life-changing weight loss that some patients ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.

Donald Trump had to be ‘guided back’ on stage following his tariff-touting speech after ‘forgetting’ to sign his executive ...